Obesity: Surgical and Pharmaceutical Options & Navigating Diet Trends

Obesity: Surgical and Pharmaceutical Options & Navigating Diet Trends

Obesity: Surgical and Pharmaceutical options & Navigating diet trends Guillermo Higa MD, FACS, FASMBS Bariatric Surgery Medical Director Chief of Division of Bariatric Surgery St. Mary’s Hospital Tucson-Arizona What is Obesity? The Obesity Medicine Association Definition of Obesity • “Obesity is defined as a chronic, relapsing, multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical, and psychosocial health consequences.” Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Obesity is common, serious, and costly • The prevalence of obesity was 39.8% and affected about 93.3 million of US adults in 2015-2016. • Obesity-related conditions include heart disease, stroke, type 2 diabetes and certain types of cancer that are some of the leading causes of preventable, premature death. • The estimated annual medical cost of obesity in the United States was $147 billion in 2008 US dollars; the medical cost for people who have obesity was $1,429 higher than those of normal weight. https://www.cdc.gov/obesity/data/adult.html Obesity Kills • Leading cause of preventable death • Recently surpassed smoking as leading cause • Lifespan shortened 9 - 12 years • Over 400,000 deaths per year • 46 deaths each hour Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2017 ¶ Prevalence estimates reflect BRFSS methodological changes started in 2011. These estimates should not be compared to prevalence estimates before 2011. *Sample size <50 or the relative standard error (dividing the standard error by the prevalence) ≥ 30%. Obesity Prevalence • In 2015 – 2016, the prevalence of obesity is estimated to be ~ 40% in US adults, and 18.5% of youths • The prevalence of obesity is higher among non-Hispanic black and Hispanic adults than among non-Hispanic white and non-Hispanic Asian adults and youth • At least since 1999, the trend towards an increase in prevalence in obesity continues to increase among adults and youths Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [2] Obesity as a Multifactorial Disease Genetics/ Epigenetics Neurobehavioral Environment (Social/Culture) Medical Immune Endocrine Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Obesity: Epigenetic Etiology/Causes Epigenetics: Alterations in gene expression without alteration in the genetic code Pre-pregnancy • Pre-conception paternal or maternal overweight/obesity may influence epigenetic signaling during subsequent pregnancy: ‒ Increased risk of overweight/obesity in offspring ‒ Increased risk of other diseases (e.g., cardiovascular disease, cancer, diabetes mellitus, etc.) in offspring Pregnancy • Especially in the presence of gestational diabetes mellitus, unhealthy maternal nutrition in women who are pregnant and overweight or with obesity may increase placental nutrient transfer to fetal circulation: ‒ Glucose ‒ Lipids and fatty acids ‒ Amino acids • Increased maternal nutrient transport may alter fetal gene expression: ‒ Covalent modifications of deoxynucleic acid and chromatin ‒ May impact stem cell fate ‒ May alter postnatal biologic processes involved in substrate metabolism ‒ May increase offspring predisposition to overweight/obesity and other diseases Post-pregnancy • Adverse effects of epigenetic pathologies may help account for generational obesity • Improvement in generational obesity in offspring will likely require generational change in nutrition and physical activity in prior generations of parents Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [7] [11] [12] Obesity: Extragenetic Etiology/Causes Extragenetic • Environment (family, home, geographic location) • Culture • Lack of optimal nutrition and physical activity • Disrupted sleep (e.g., poor quality, too little, or too much) • Adverse consequences of medications • Mental stress • Neurologic dysfunction (central nervous system trauma, hypothalamic inflammation, leptin resistance) • Viral infections • Gut microbiota neurologic signaling and transmission of pro-inflammatory state Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [7] Obesity is common, serious, and costly • The prevalence of obesity was 39.8% and affected about 93.3 million of US adults in 2015-2016. • Obesity-related conditions include heart disease, stroke, type 2 diabetes and certain types of cancer that are some of the leading causes of preventable, premature death. • The estimated annual medical cost of obesity in the United States was $147 billion in 2008 US dollars; the medical cost for people who have obesity was $1,429 higher than those of normal weight. https://www.cdc.gov/obesity/data/adult.html Obesity Algorithm Obesity as a Disease Data Collection Evaluation and Assessment Management Decisions Motivational Interviewing Nutritional Behavior Pharmaco- Bariatric Physical Activity Intervention Therapy therapy Procedures Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [1] Which Is the “Best” Measure of Obesity? Population Assessment • Body mass index (BMI), waist circumference (WC), and percent body fat (%BF) similarly correlate with prevalence of metabolic syndrome Individual Assessment • BMI is a reasonable initial screening measurement for most patients • WC provides additional information regarding adipose tissue function/dysfunction and predisposition to metabolic disease among individuals with BMI<35 kg/m2 • %BF may be more useful in patients with extremes in muscle mass (i.e., individuals with sarcopenia or substantial increases in muscle mass), and thus may be a more accurate measure of body composition when assessing the efficacy of interventions directed towards change in muscle mass Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [1] BMI = weight (kg)/height (m²) = [weight (lbs)/height (in²)] x 703 Acceptable Weight 18 – 25 Overweight 25 – 30 Obese 30 – 35 Severe Obesity 35 – 40 Morbid Obesity 40 – 50 Super Morbid Obesity above 50 Waist Circumference: Increased Body Fat (Adiposity) Obesity classification: Waist circumference (WC)* Abdominal Obesity - Men Abdominal Obesity - Women > 40 inches > 35 inches > 102 centimeters > 88 centimeters *Different WC abdominal obesity cut-off points are appropriate for different races (i.e., > 90 centimeters for Asian men and > 80 centimeters for Asian women) Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [23] [24] [25] [26] Waist Circumference Advantages • Well-correlated to metabolic disease • Direct anatomical measure of adipose tissue deposition, with an increase in waist circumference reflective of adipose tissue dysfunction • Low cost Disadvantages • Measurement not always reproducible • Waist circumference is not superior to BMI in correlating to metabolic disease in patients with BMI > 35 kg/m2 • Racial/ethnic differences Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [24] [25] [26] Overall Management Goals Adult patient with overweight or obesity Improve patient Improve quality Improve body weight health of life and composition Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Obesity Algorithm Obesity as a Disease Data Collection Evaluation and Assessment Management Decisions Motivational Interviewing Nutritional Behavior Pharmaco- Bariatric Physical Activity Intervention Therapy therapy Procedures Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [1] Motivational Interviewing Techniques: 5A’s of Obesity Management • Ask for permission to discuss body weight. Ask • Explore readiness for change. • Assess BMI, waist circumference, and obesity stage. Assess • Explore drivers and complications of excess weight. • Advise the patient about the health risks of obesity, the benefits of modest weight loss (i.e., 5-10 percent), the need for long-term strategy, and Advise treatment options. • Agree on realistic weight-loss expectations, targets, behavioral changes, Agree and specific details of the treatment plan. • Assist in identifying and addressing barriers; provide resources; assist in finding and consulting with appropriate providers; arrange regular follow Arrange/Assist up. Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [226] [227] Motivational Interviewing: Stages of Change Pre-contemplation Progress Unawareness of the problem Contemplation Thinking of change in the next 6 months Preparation Making plans to change now Action Implementation of change Relapse Restart of unfavorable behavior Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [204] [205] Treatment of Adult Patients with Overweight or Obesity Medical Management and Coordination Nutrition Physical Activity Behavior Therapy Pharmacotherapy Bariatric Surgery Obesity Algorithm®. ©2017-2018 Obesity Medicine Association. Reference/s: [1] Nutritional Therapy for Obesity Nutrition History Meals and Snacks Behavior Records • Timing • Previous nutritional attempts to • Food and beverage diary, • Frequency (via questionnaire) lose weight and/or change body including type of food or • Nutritional content composition beverage consumed and amount • Preparer of food ‒ If unsuccessful or un- consumed • Access to foods sustained, what were ‒ 72-hour recall • Location of home food short- and long-term ‒ Keep food and beverage consumption (i.e., eating area, barriers to achieving or record

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    79 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us